Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Journal of Neurochemistry|December 8, 2011
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathwaysGinetta Collo, Federica Bono, Laura Cavalleri, et al.
Addiction Biology|March 16, 2013
Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the ratLuigi Cervo, Angelo Di Clemente, Alessandro Orrù, et al.
Behavioural Pharmacology|July 10, 2012
Effect of dopamine D₃ receptor antagonism on approach responses to food cues in overweight and obese individualsKarin Mogg, Brendan P Bradley, Barry O'Neill, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|June 8, 2011
A randomized, controlled study comparing the effects of vestipitant or vestipitant and paroxetine combination in subjects with tinnitusClaire Roberts, Amir Inamdar, Annelize Koch, et al.
The International Journal of Neuropsychopharmacology|March 27, 2014
Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorderVanda Faria, Fredrik Ahs, Lieuwe Appel, et al.
Psychiatry Research|July 20, 2012
Altered brain functional connectivity in relation to perception of scrutiny in social anxiety disorderMónica Giménez, Jesús Pujol, Hector Ortiz, et al.
International Journal of Dentistry|March 10, 2022
Probiotics-Containing Mucoadhesive Gel for Targeting the Dysbiosis Associated with Periodontal DiseasesGiuseppe Giannini, Irene Ragusa, Giulia Nerina Nardone, et al.
British Journal of Clinical Pharmacology|January 13, 2011
Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy menMarieke Liem-Moolenaar, Mandana Rad, Stefano Zamuner, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approachAmir Inamdar, Emilio Merlo-Pich, Michelle Gee, et al.
Frontiers in Pharmacology|June 20, 2022
Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic NeuronsRosamaria Orlando, Roxana Paula Ginerete, Laura Cavalleri, et al.
Pageof 10